The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

By G. Conway, Didier Dewailly, E. Diamanti-Kandarakis, H. Escobar-Morreale, S. Franks, A. Gambineri, F. Keleştimur, D. Macut, D. Mićić, R. Pasquali and 4 more. European Journal of Endocrinology, 2014

604 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/518b85a010c577bc0434b3172e959aaf7980d719

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Bart C. J. M. Fauser
2. R. Norman

In Public Health, Environmental and Occupational Health

1. Bart C. J. M. Fauser
2. R. Norman
3. Didier Dewailly
4. R. Legro
5. L. Moran
6. Frank J. Broekmans

In Reproductive Medicine

1. Bart C. J. M. Fauser
2. R. Norman
3. R. Legro
4. J. Laven
5. Frank J. Broekmans
6. Didier Dewailly
7. L. Moran
8. R. Azziz

Citations in the corpus

• Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018, background): “Current guidelines either are limited in breadth, do not follow rigorous best practice in development, have not involved consumers, or are outdated (6-10), resulting in inconsistent guidance for clinicians and women alike.”